search reports
Categories
Categories

Migraine- Disease overview

Report Code : prcr0021
Published Date : 01 January, 2018 | No of Pages: 21

  • Report Description
  • Table of Contents
  • Companies Mentioned
  • Related Reports
Migraine is known to be one of the three most prevalent diseases in the world and the disease is prevalent in around 14% of the entire world population. In the US, the prevalence of Migraine is around 12% of the US population.

The report gives the overview of Migraine disease indication in detail. The report starts with the basic definition, causes and symptoms of Migraine and further details the types of Migraine disease indication.

The report covers further details on the profile of an Migraine patient, Symptoms of Migraine patient, and disease progression in a Migraine patient. The report further highlights the multiple methods through which the patient can be diagnosed for Migraine.
Migraine Definition
Classification of Migraine based on symptoms and severity and based on frequency of attacks
Causes of Migraine
Profile of Migraine patient
Symptoms of Migraine patient
Disease progression and impact on QoL
Disease diagnosis
Market Intel Report Migraine- Disease overview and Epidemiology
By: Pharmascroll Research and Consulting Pvt Ltd | Published Date : 01 January, 2018 | No of Pages : 30
Market Intel Report Migraine- Disease overview, Epidemiology and Drug overview
By: Pharmascroll Research and Consulting Pvt Ltd | Published Date : 01 January, 2018 | No of Pages : 77
Teva Novartis Amgen Allergan Alder Eli Lilly Pfizer Glaxo Smithkline Briston Mayers Allodynic Therapeutics Pharmalyte Solutions Ionis Pharmaceuticals Helsinn Group Otsuka Holdings NeurAxon Inc. Achelios Therapeutics Trigemina
Please select License
Single User Price:$ 1000
Site License Price:$ 3000